Rheumatic Disease Clinics of North America

Papers
(The median citation count of Rheumatic Disease Clinics of North America is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Copyright105
Contents86
Pediatric Rheumatology Comes of Age: Part II59
Implementation Science in Pediatric Rheumatology: A Path to Health Equity36
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases33
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children23
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network22
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis22
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis20
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy16
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis16
Osteoarthritis Treatment Guidelines from Six Professional Societies16
Copyright14
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota14
Forthcoming Issues13
COPA Syndrome from Diagnosis to Treatment13
The Short and Long of COVID-1912
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica12
Lessons Learned from the COVID-19 Pandemic in Rheumatology12
Taxonomy of Quality of Care Indicators11
Imaging Challenges and Developments in Large-vessel Vasculitis11
Newer Immunosuppressants for Rheumatologic Disease10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events10
Venous Thromboembolism in the Inflammatory Rheumatic Diseases10
Pulmonary Hypertension Associated with Connective Tissue Disease10
Contributors10
It Takes Oysters to Generate Pearls9
Expanding the Treatment Team9
Contents8
Copyright8
De novo Connective Tissue Disorders as Immune-related Adverse Events8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease8
Primary Cardiac Involvement in Systemic Sclerosis8
Vaccinations in Patients with Rheumatic Disease8
Copyright8
Daniel J McCarty, MD: A Giant of Rheumatology8
Rheumatology Pearls for the Primary Care Physician7
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease7
Scleroderma: Best Approaches to Patient Care7
COVID-19 and Rheumatology7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis7
Preventative Care in Scleroderma7
Charles L Christian7
Cardiac MRI in Rheumatic Disease6
Copyright6
A Guide to Contemporary Clinical Practice Guidelines6
E Carwile LeRoy, MD6
Imaging of Pulmonary Manifestations of Connective Tissue Disease6
Contents6
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 20196
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD6
Guideline Development and Implementation in Rheumatic Disease6
The Challenges of New Biologic Therapies in Pediatrics6
Beyond Coronary Artery Disease5
The Role of Psychology in Pediatric Rheumatic Diseases5
Imaging of the Major Salivary Glands in Rheumatic Disease5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus5
Myositis5
Copyright5
Forthcoming Issues5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy5
Contents5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis5
Contributors5
Heart Failure in Rheumatic Disease5
Contributors5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”4
Treatment Guidelines in Pediatric Rheumatic Diseases4
Treatment Guidelines in Gout4
Patient Engagement in Pediatric Rheumatology Research4
Management and Cure of Gouty Arthritis4
Dual-Energy Computed Tomography Applications in Rheumatology4
Genetic Defects in Early-Onset Inflammatory Bowel Disease4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
SARS-CoV-2 Infection and COVID-19 in Children4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury4
Cardiovascular Health in Pediatric Rheumatologic Diseases4
Copyright4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk4
Role of Environment in Pediatric Rheumatic Diseases4
Achieving Precision Medicine in Psoriatic Arthritis4
The GRADE Method3
Contents3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis3
Pediatric Rheumatic Disease in Lower to Middle-Income Countries3
Interstitial Lung Disease3
Mental Health in Pediatric Rheumatology3
Pediatric Rheumatology Comes of Age: Part II3
Expanding IPEX: Inborn Errors of Regulatory T Cells3
Health Care Utilization3
Diagnostic Evaluation for Myositis and Their Pitfalls3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica3
Forthcoming Issues3
Imaging in Inflammatory Bowel Disease3
Contents3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model3
Technology to Assess and Treat Pain in Pediatric Rheumatology3
Forthcoming Issues2
J. Claude Bennett, MD2
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future2
Emerging Treatment Options for Inclusion Body Myositis2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis2
Perioperative Management of Rheumatic Disease and Therapies2
Contributors2
Training the Next Generation of Rheumatologists2
Imaging in Juvenile Idiopathic Arthritis2
Patient-Reported Outcomes in Myositis2
Forthcoming Issues2
Forthcoming Issues2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases2
Forthcoming Issues2
Gerald P Rodnan1
Vasculitis1
Treatment of Vascular Complications in Systemic Sclerosis1
Cardiovascular Disease in Large Vessel Vasculitis1
Foreword1
Long COVID for the Rheumatologist1
Treatment of Inflammatory Arthritis in Systemic Sclerosis1
Axial Imaging in Spondyloarthritis1
Foreword1
Forthcoming Issues1
Nathan Zvaifler1
Systemic Diseases and Heart Block1
Targeting Environmental Risks to Prevent Rheumatic Disease1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis1
Foreword1
The Mythology of Polymyositis1
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis1
Transitioning to Adulthood with a Rheumatic Disease1
Treatment Guidelines in Vasculitis1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy1
Imaging in Rheumatology1
Preface1
Precision Medicine1
The Promises and Perils of Social Media for Pediatric Rheumatology1
The Current and Future of Biomarkers of Immune Related Adverse Events1
The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis1
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis1
Targeted Treatment of Diseases of Immune Dysregulation1
Highlights of Interdisciplinary Care in Rheumatology1
Contributors1
Forthcoming Issues1
Contributors1
The Giants Of Rheumatology1
Central Nervous System Imaging in Rheumatic Diseases0
Coronavirus Disease-2019 in the Immunocompromised Host0
Forthcoming Issues0
Forthcoming Issues0
Contributors0
Copyright0
Vasculitis and Pregnancy0
Recommendations for Systemic Lupus Erythematosus0
Forthcoming Issues0
Systemic Autoinflammatory Diseases0
Managing Cardiovascular Risk in Patients with Rheumatic Disease0
New Developments in Imaging in Crystalline Arthritis0
Pediatric Rheumatology Comes of Age: Part II0
Interventions to Improve COVID-19 Vaccine Hesitancy0
Contents0
Environmental Risks for Spondyloarthropathies0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology0
Copyright0
Suppressor of Cytokine Signaling 1 Haploinsufficiency0
Contributors0
Best Approaches to the Care of Systemic Sclerosis Patients0
Cardiovascular Complications of Chronic Rheumatic Diseases0
Management of Lung Manifestations in Idiopathic Inflammatory Myopathies0
Forthcoming Issues0
Vasculitis0
Foreword0
Contributors0
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome0
Immunotherapy Toxicity Management in Clinical Practice0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis0
Autoantibodies in Myositis0
Systemic Lupus Erythematosus Risk0
Calcinosis in Adult and Juvenile Dermatomyositis0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression0
Disparities in Pediatric Rheumatic Diseases0
Approach to Systemic Sclerosis Patient Assessment0
Contributors0
Forthcoming Issues0
Type I Interferonopathies0
Guideline Development and Implementation in Rheumatic Disease0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis0
Vasculitis Mimics and Other Related Conditions0
Edmund Lawrence Dubois (1923–1985)0
Scleroderma: Best Approaches to Patient Care0
The Future of Vasculitis0
Lung Microbiome in Autoimmune-Associated Interstitial Lung Disease0
Naomi Rothfield, MD, MACR0
Environmental Risks for Inflammatory Myopathies0
Rheumatic Immune-related Adverse Events0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease0
How the American College of Rheumatology Develops Guidelines0
Mental Health Considerations in Chronic Disease0
Rheumatoid Arthritis0
Giant Cell Arteritis and Polymyalgia Rheumatica0
Newer Immunosuppressants for Rheumatologic Disease0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination0
Environmental Triggers for Rheumatic Diseases0
Rheumatology Pearls for the Primary Care Physician0
Emerging Concepts in the Diagnosis and Treatment of Systemic Vasculitis0
Eric Bywaters and Barbara Ansell0
Environmental Triggers for Rheumatic Diseases0
Imaging in Rheumatology0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases0
Imaging Revolutions in Modern Rheumatology0
Immune Checkpoint Inhibitor-induced Sicca Syndrome0
Patient Experience of Systemic Sclerosis–Related Calcinosis0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development0
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders0
Lessons from Carl M. Pearson 1919 – 19810
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination0
Contributors0
Contributors0
Lessons on Telemedicine in Rheumatology0
Psoriatic Arthritis Updates0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases0
The Emerging Telehealth Landscape in Pediatric Rheumatology0
Emerging Concepts in Immune Dysregulation0
Contents0
Contents0
Axial Psoriatic Arthritis0
Foreword0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases0
Gastrointestinal Tract Considerations: Part II0
Isolated Aortitis0
Updates in the Management of Immune-Mediated Necrotizing Myopathy0
Central Nervous System Vasculitis0
Imaging of Rheumatic Diseases Affecting the Lower Limb0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis0
Copyright0
Emerging Concepts in Immune Dysregulation0
Rheumatic Immune-Related Adverse Events: Current Clinical Imperatives Underpin Future Novel Insights0
Scleroderma Skin0
Forthcoming Issues0
Environmental Risks for Systemic Sclerosis0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients0
Gut and Joint Microbiomes0
Environmental Triggers for Vasculitis0
New and Emerging Rheumatic Diseases0
0.15967106819153